Biohaven Ltd. (BHVN): Shareholders' Equity
$52.07M
As of 2025-12-31
$12.22M
As of 2026-06-30
-54.1%
3-year compound annual growth
+25.4%
5-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $52.07M | -87.7% | 2026-03-02, Balance as of period end |
| 2024-12-31 | $423.44M | -1.1% | 2026-03-02, Balance as of period end |
| 2023-12-31 | $427.98M | -20.6% | 2026-03-02, Balance as of period end |
| 2022-12-31 | $538.77M | n/m | 2025-03-03, Balance as of period end |
| 2021-12-31 | $34.69M | +106.7% | 2024-02-29, Balance as of period end |
| 2020-12-31 | $16.78M | n/a | 2023-03-23, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Biohaven Ltd. (BHVN) | 2025-12-31 | $52.07M | -87.7% |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | 2025-12-31 | $411.10M | n/m |
| BGM Group Ltd. (BGM) | 2025-09-30 | $391.90M | +788.8% |
| Arcutis Biotherapeutics, Inc. (ARQT) | 2025-12-31 | $189.48M | +20.3% |
| Bicara Therapeutics Inc. (BCAX) | 2025-12-31 | $401.45M | -18.4% |
| Enliven Therapeutics, Inc. (ELVN) | 2025-12-31 | $459.60M | +48.3% |
| MapLight Therapeutics, Inc. (MPLT) | 2025-12-31 | $458.37M | n/m |
| MoonLake Immunotherapeutics (MLTX) | 2025-12-31 | $304.48M | -31.9% |
| Rhythm Pharmaceuticals, Inc. (RYTM) | 2025-12-31 | $139.07M | +540.0% |
Compare BHVN, BBOT, BGM, ARQT side by side · Screen every company in Pharmaceutical Preparations ↗